Evidence map›Paper›PMID 25559184›Full record

ArticleThe Journal of cell biology2015

Rac1 functions as a reversible tension modulator to stabilize VE-cadherin trans-interaction.

Nazila Daneshjou, Nathan Sieracki, Geerten P van Nieuw Amerongen, Daniel E Conway, Martin A Schwartz, Yulia A Komarova, Asrar B Malik

Erratum issuedOpen access · hybridAbstract readVideo-Audio Media
In one paragraph

Article in The Journal of cell biology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 42 papers.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed
6.9field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 74 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. DOCK4 Regulation of Rho GTPases Mediates Pulmonary Vascular Barrier Function.Arteriosclerosis, thrombosis, and vascular biology · 2022
    Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Post-translational modifications of S1PR1 and endothelial barrier regulation.Biochimica et biophysica acta. Molecular and cell biology of lipids · 2020
    Review
  16. Article
  17. Review
  18. The Importance of Mechanical Forces forFrontiers in physiology · 2020
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 6 institutions in 2 countries.

Nazila DaneshjouDepartment of Pharmacology, University of Illinois College of Medicine, Chicago, IL 60612.
Nathan SierackiDepartment of Pharmacology, University of Illinois College of Medicine, Chicago, IL 60612.
Geerten P van Nieuw AmerongenDepartment of Physiology, Institute for Cardiovascular Research, Vrije University of Amsterdam, 1081 HV Amsterdam, Netherlands.
Daniel E ConwayDepartment of Cell Biology, Yale University School of Medicine, New Haven, CT 06510.
Martin A SchwartzDepartment of Biomedical Engineering, Virginia Commonwealth University, Richmond, VA 23284.
Yulia A KomarovaDepartment of Cell Biology, Yale University School of Medicine, New Haven, CT 06510.
Asrar B MalikDepartment of Cell Biology, Yale University School of Medicine, New Haven, CT 06510.
University of Illinois Chicago · USIllinois College · USUniversity of Illinois Urbana-Champaign · USVirginia Commonwealth University · USVrije Universiteit Amsterdam · NLYale University · US

Funding

TRPC6 Regulation of Lung Endothelial Barrier FunctionP01HL060678 · NHLBI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI MALIK, ASRAR B. · 2000 to 2020
$40.1M
TRAINING PROGRAM IN LUNG BIOLOGY AND PATHOBIOLOGYT32HL007829 · NHLBI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI DOLLY MEHTA · 1995 to 2026
$15.6M
THROMBIN-INDUCED PULMONARY VASCULAR PERMEABILITYR01HL045638 · NHLBI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI KOMAROVA, YULIA A · 1991 to 2025
$12.0M
Integrins in the Endothelial Response to Fluid Shear StressR01HL075092 · NHLBI · YALE UNIVERSITY · PI SCHWARTZ, MARTIN A · 2004 to 2019
$5.1M
Role of End Binding 3 in Mechanism of vascular permeabilityR01HL103922 · NHLBI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI KOMAROVA, YULIA A · 2011 to 2014
$1.5M
NHLBI NIH HHS P01 HL060678NHLBI NIH HHS P01 HL60678NHLBI NIH HHS R01 HL045638NHLBI NIH HHS R01 HL075092NHLBI NIH HHS R01 HL103922NHLBI NIH HHS R01 HL45638NHLBI NIH HHS T32 HL007829NHLBI NIH HHS T32 HL007829-18
6 · The paper itself

Abstract

The role of the RhoGTPase Rac1 in stabilizing mature endothelial adherens junctions (AJs) is not well understood. In this paper, using a photoactivatable probe to control Rac1 activity at AJs, we addressed the relationship between Rac1 and the dynamics of vascular endothelial cadherin (VE-cadherin). We demonstrated that Rac1 activation reduced the rate of VE-cadherin dissociation, leading to increased density of VE-cadherin at AJs. This response was coupled to a reduction in actomyosin-dependent tension across VE-cadherin adhesion sites. We observed that inhibiting myosin II directly or through photo-release of the caged Rho kinase inhibitor also reduced the rate of VE-cadherin dissociation. Thus, Rac1 functions by stabilizing VE-cadherin trans-dimers in mature AJs by counteracting the actomyosin tension. The results suggest a new model of VE-cadherin adhesive interaction mediated by Rac1-induced reduction of mechanical tension at AJs, resulting in the stabilization of VE-cadherin adhesions.

Indexed as

Adherens JunctionsAntigens, CDCadherinsEndothelial Cellsrac1 GTP-Binding ProteinActomyosinCadherin 5Cell AdhesionCells, CulturedEnzyme ActivationHumansKineticsMicroscopy, FluorescenceMicroscopy, VideoModels, BiologicalMyosin Type IIActomyosinAntigens, CDCadherin 5CadherinsMyosin Type IIProtein Kinase Inhibitorsrac1 GTP-Binding ProteinRAC1 protein, humanrho-Associated Kinases

Identifiers

PMID25559184
PMCPMC4284224
OpenAlexW2145518607

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.